Charis L. Himeda

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?”.

FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?

Journal of Personalized Medicine(2022)10.3390/jpm12060865

N/A

0.406DataRank · unranked

14 citations

Peter L. Jones, Charis L. Himeda

Have a Little Heart (or Not): Highly Minimized Skeletal Muscle Regulatory Cassettes with Low or No Activity in the Heart

Human Gene Therapy(2024)10.1089/hum.2024.041

N/A

0DataRank · unranked

3 citations

Takako I. Jones, Peter L. Jones, Charis L. Himeda

All-in-one vectors for epigenetic CRISPR inhibition of DUX4-fl in facioscapulohumeral muscular dystrophy

Molecular Therapy — Methods & Clinical Development(2025)10.1016/j.omtm.2025.101546

N/A

0DataRank · unranked

1 citations

Takako I. Jones, Peter L. Jones, Charis L. Himeda

Transgenic mouse models for investigating human DUX4 expression during development and its roles in FSHD pathophysiology

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.22.671867

N/A

0DataRank · unranked

0 citations

Charis L. Himeda, Peter L. Jones, Takako I. Jones, Yosuke Hiramuki